NL300318I2 - Papillomavirus vaccins - Google Patents

Papillomavirus vaccins

Info

Publication number
NL300318I2
NL300318I2 NL300318C NL300318C NL300318I2 NL 300318 I2 NL300318 I2 NL 300318I2 NL 300318 C NL300318 C NL 300318C NL 300318 C NL300318 C NL 300318C NL 300318 I2 NL300318 I2 NL 300318I2
Authority
NL
Netherlands
Prior art keywords
antibodies
useful
papillomavirus vaccines
vaccines
mimics
Prior art date
Application number
NL300318C
Other languages
English (en)
Other versions
NL300318I1 (nl
Original Assignee
Univ Georgetown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25416951&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300318(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Georgetown filed Critical Univ Georgetown
Publication of NL300318I1 publication Critical patent/NL300318I1/nl
Publication of NL300318I2 publication Critical patent/NL300318I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
NL300318C 1992-06-25 2007-12-14 Papillomavirus vaccins NL300318I2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90310992A 1992-06-25 1992-06-25
PCT/US1993/006109 WO1994000152A1 (en) 1992-06-25 1993-06-24 Papillomavirus vaccines

Publications (2)

Publication Number Publication Date
NL300318I1 NL300318I1 (nl) 2008-02-01
NL300318I2 true NL300318I2 (nl) 2008-03-03

Family

ID=25416951

Family Applications (8)

Application Number Title Priority Date Filing Date
NL300317C NL300317I1 (nl) 1992-06-25 2007-12-14 Papillomavirus vaccins
NL300315C NL300315I2 (nl) 1992-06-25 2007-12-14 Papillomavirus vaccines
NL300319C NL300319I1 (nl) 1992-06-25 2007-12-14 Papillomavirus vaccins
NL300318C NL300318I2 (nl) 1992-06-25 2007-12-14 Papillomavirus vaccins
NL300321C NL300321I1 (nl) 1992-06-25 2007-12-14 Papillomavirus vaccins
NL300322C NL300322I1 (nl) 1992-06-25 2007-12-14 Papillomavirus vaccins
NL300320C NL300320I1 (nl) 1992-06-25 2007-12-14 Papillomavirus vaccins
NL300316C NL300316I1 (nl) 1992-06-25 2007-12-14 Papillomavirus vaccins

Family Applications Before (3)

Application Number Title Priority Date Filing Date
NL300317C NL300317I1 (nl) 1992-06-25 2007-12-14 Papillomavirus vaccins
NL300315C NL300315I2 (nl) 1992-06-25 2007-12-14 Papillomavirus vaccines
NL300319C NL300319I1 (nl) 1992-06-25 2007-12-14 Papillomavirus vaccins

Family Applications After (4)

Application Number Title Priority Date Filing Date
NL300321C NL300321I1 (nl) 1992-06-25 2007-12-14 Papillomavirus vaccins
NL300322C NL300322I1 (nl) 1992-06-25 2007-12-14 Papillomavirus vaccins
NL300320C NL300320I1 (nl) 1992-06-25 2007-12-14 Papillomavirus vaccins
NL300316C NL300316I1 (nl) 1992-06-25 2007-12-14 Papillomavirus vaccins

Country Status (12)

Country Link
US (2) US20020068326A1 (nl)
EP (2) EP0647140B1 (nl)
AT (1) ATE380871T1 (nl)
AU (1) AU697743C (nl)
DE (9) DE122007000096I1 (nl)
DK (1) DK0647140T3 (nl)
ES (1) ES2294778T3 (nl)
FR (1) FR07C0073I2 (nl)
LU (8) LU91395I2 (nl)
NL (8) NL300317I1 (nl)
PT (1) PT647140E (nl)
WO (1) WO1994000152A1 (nl)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000018I1 (de) 1991-07-19 2007-05-24 Univ Queensland Polynukleotidabschnitt des HPV16-Genoms
US5437951A (en) * 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
US6153201A (en) * 1993-03-09 2000-11-28 University Of Rochester Oral immunization with papillomavirus virus-like particles
US8062642B1 (en) 1993-03-09 2011-11-22 University Of Rochester Production of papillomavirus capsid protein and virus-like particles
DE4415743C2 (de) * 1994-05-04 1996-10-10 Deutsches Krebsforsch Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen
RU2206608C2 (ru) * 1994-05-16 2003-06-20 Мерк Энд Ко., Инк. Папилломавирусные вакцины
US5888516A (en) * 1994-05-16 1999-03-30 Merck & Co. Inc. Recombinant papillomavirus vaccines
AU683564B2 (en) * 1994-05-17 1997-11-13 University Of Queensland, The Recombinant papilloma virus L1
AUPM566794A0 (en) * 1994-05-17 1994-06-09 University Of Queensland, The Process and product
NZ293461A (en) * 1994-09-22 1998-04-27 Merck & Co Inc Dna encoding human papillomavirus type 6a, compounds derived therefrom
PT809700E (pt) 1994-10-07 2006-09-29 Univ Loyola Chicago Particulas semelhantes ao papilomavirus e proteinas de fusao, assim como metodos para a sua producao
IL117459A (en) * 1995-03-22 2005-11-20 Merck & Co Inc Dna encoding human papillomavirus type 18
US5820870A (en) * 1995-03-22 1998-10-13 Merck & Co., Inc. Recombinant human papillomavirus type 18 vaccine
US5840306A (en) * 1995-03-22 1998-11-24 Merck & Co., Inc. DNA encoding human papillomavirus type 18
US6908615B1 (en) 1996-03-18 2005-06-21 Merck & Co., Inc. DNA encoding human papilloma virus type 18
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
EP1000157A1 (en) * 1997-07-03 2000-05-17 University Technology Corporation Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy
US6228368B1 (en) 1997-10-06 2001-05-08 Loyola University Of Chicago Papilloma virus capsomere formulations and method of use
CA2229955C (en) 1998-02-20 2003-12-09 Medigene Gmbh Papilloma virus capsomere vaccine formulations and methods of use
US7494658B2 (en) 1998-02-20 2009-02-24 Medigene Ag Papilloma virus truncated L1 protein and fusion protein constructs
US7182947B2 (en) 1998-02-20 2007-02-27 Medigene Ag Papillomavirus truncated L1 protein and fusion protein constructs
US20020039584A1 (en) 1998-02-20 2002-04-04 Medigene Ag Papilloma virus capsomere vaccine formulations and methods of use
US6926897B1 (en) 1998-03-24 2005-08-09 Medigene Aktiengesellschaft Medicament for the avoidance or treatment of papillomavirus-specific tumour
US6242176B1 (en) 1998-07-13 2001-06-05 Loyola University Of Chicago Papillomavirus cellular receptor
US6692752B1 (en) 1999-09-08 2004-02-17 Smithkline Beecham Biologicals S.A. Methods of treating human females susceptible to HSV infection
PL201482B1 (pl) * 1998-10-16 2009-04-30 Smithkline Beecham Biolog Sposoby wytwarzania kompozycji szczepionki oraz kompozycja szczepionki
GB0109297D0 (en) 2001-04-12 2001-05-30 Glaxosmithkline Biolog Sa Vaccine
EP1425423B1 (en) 2001-08-13 2010-06-23 University of Rochester Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles
GB0206360D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
DK1648931T3 (da) 2003-07-21 2011-03-07 Transgene Sa Multifunktionelle cytokiner
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
EP2486938B1 (en) 2006-09-26 2018-05-09 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
MX2009009342A (es) 2007-03-02 2009-09-11 Glaxosmithkline Biolog Sa Metodo novedoso y composiciones.
CN102099053A (zh) 2008-05-26 2011-06-15 卡迪拉保健有限公司 麻疹-人乳头瘤组合疫苗
GB0815872D0 (en) 2008-09-01 2008-10-08 Pasteur Institut Novel method and compositions
GB0820822D0 (en) 2008-11-13 2008-12-24 Inst Catala D Oncologia Novel product and processes
EP2414512A1 (en) * 2009-04-03 2012-02-08 Deutsches Krebsforschungszentrum Enhanced production of papillomavirus-like particles with a modified baculovirus expression system
TWI494125B (zh) 2009-06-05 2015-08-01 Infectious Disease Res Inst 合成的葡萄吡喃糖基脂質佐劑
WO2011026111A1 (en) 2009-08-31 2011-03-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Oral delivery of a vaccine to the large intestine to induce mucosal immunity
CA2795403C (en) 2010-04-08 2019-01-15 University Of Pittsburgh-Of The Commonwealth System Of Higher Education B-cell antigen presenting cell assay
JP6054942B2 (ja) 2011-04-08 2016-12-27 イミューン デザイン コーポレイション 免疫原性組成物、ならびに体液性および細胞性免疫応答を誘発するための該組成物の使用方法
US11510875B2 (en) 2012-02-07 2022-11-29 Access To Advanced Health Institute Adjuvant formulations comprising TLR4 agonists and methods of using the same
BR112014028476A2 (pt) 2012-05-16 2017-08-01 Immune Design Corp fragmento imunogênico de um polipeptídeo, polinucleotídeo isolado, composição farmacêutica imunogênica, métodos para tratar uma infecção, para gerar uma resposta imune em um sujeito, e para imunizar um sujeito
CN104870477B (zh) 2012-10-23 2018-10-09 爱默蕾大学 Gm-csf和il-4轭合物、组合物以及与其相关的方法
EA032326B1 (ru) 2013-04-18 2019-05-31 Иммьюн Дизайн Корп. Монотерапия gla для применения в лечении рака
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
AU2014373928C1 (en) 2013-12-31 2020-12-17 Access To Advanced Health Institute Single vial vaccine formulations
WO2017144359A1 (en) 2016-02-22 2017-08-31 Boehringer Ingelheim Vetmedica Gmbh Method for the immobilization of biomolecules
CN109310773B (zh) 2016-05-16 2022-04-26 传染病研究所 含有tlr激动剂的配制品和使用方法
MX2018013640A (es) 2016-05-16 2019-08-01 Infectious Disease Res Inst Liposomas pegiladas y metodos de uso.
AU2017273650B2 (en) 2016-06-01 2022-08-18 Access To Advanced Health Institute Nanoalum particles containing a sizing agent
EP3638207A1 (en) 2017-06-15 2020-04-22 Infectious Disease Research Institute Nanostructured lipid carriers and stable emulsions and uses thereof
JP7339942B2 (ja) 2017-09-08 2023-09-06 アクセス ツー アドバンスト ヘルス インスティチュート サポニンを含むリポソーム製剤および使用方法
BR112021023726A2 (pt) 2019-05-25 2022-02-15 Infectious Disease Res Inst Composição e método para secagem por pulverização de uma emulsão de vacina adjuvante
US20230310323A1 (en) 2020-09-04 2023-10-05 Access To Advanced Health Institute Co-lyophilized rna and nanostructured lipid carrier
WO2024052882A1 (en) 2022-09-09 2024-03-14 Access To Advanced Health Institute Immunogenic vaccine composition incorporating a saponin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57106626A (en) * 1980-12-22 1982-07-02 Teijin Ltd Cytotoxic protein complex and its preparation
US4455296A (en) * 1982-02-02 1984-06-19 Board Of Regents, The University Of Texas System Hybrid cell lines producing monoclonal antibodies directed against Haemophilus influenzae
US4671958A (en) * 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
FR2524487B1 (fr) * 1982-04-05 1985-11-22 Pasteur Institut Fragments d'adn codant pour des polypeptides contenant au moins un determinant antigenique des papillomavirus, notamment du type hpv 1a et polypeptides correspondants
US4596674A (en) * 1984-09-11 1986-06-24 Merck & Co., Inc. Immunogenic HAV peptides
DE3625257A1 (de) * 1986-07-23 1988-02-04 Behringwerke Ag Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika
NZ223009A (en) * 1986-12-31 1990-06-26 Nl Rivm Of Thoven Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens
EP0320942A3 (en) * 1987-12-18 1989-10-04 American Cyanamid Company Novel polysaccharides novel macromolecular conjugates of the polysaccharides
CA2038581A1 (en) * 1990-03-20 1991-09-21 Martin Muller Seroreactive epitopes of human papillomavirus (hpv) 16 proteins
DE122007000018I1 (de) 1991-07-19 2007-05-24 Univ Queensland Polynukleotidabschnitt des HPV16-Genoms

Also Published As

Publication number Publication date
DE122007000100I1 (de) 2008-03-27
WO1994000152A1 (en) 1994-01-06
AU1135295A (en) 1996-02-08
NL300317I1 (nl) 2008-02-01
LU91397I2 (fr) 2008-02-14
DE122007000098I1 (de) 2008-03-27
EP0647140A1 (en) 1995-04-12
LU91395I2 (fr) 2008-02-14
EP1835029A1 (en) 2007-09-19
PT647140E (pt) 2007-12-27
NL300315I2 (nl) 2008-03-03
EP0647140B1 (en) 2007-12-12
NL300318I1 (nl) 2008-02-01
NL300322I1 (nl) 2008-03-03
DE122007000095I1 (de) 2008-03-27
AU697743C (en) 2007-06-14
DE122007000099I1 (de) 2008-03-27
AU697743B2 (en) 1998-10-15
EP0647140A4 (en) 1997-03-19
DE122007000096I1 (de) 2008-03-27
ES2294778T3 (es) 2008-04-01
US20020068326A1 (en) 2002-06-06
NL300319I1 (nl) 2008-03-03
DK0647140T3 (da) 2008-02-04
LU91399I2 (fr) 2008-02-14
DE122007000094I1 (de) 2008-03-27
NL300315I1 (nl) 2008-02-01
DE122007000097I1 (de) 2008-03-27
FR07C0073I2 (fr) 2012-08-03
DE69334192D1 (de) 2008-01-24
LU91396I2 (fr) 2008-02-14
DE69334192T2 (de) 2008-12-04
FR07C0073I1 (nl) 2008-01-02
LU91400I2 (fr) 2008-02-14
ATE380871T1 (de) 2007-12-15
NL300316I1 (nl) 2008-02-01
NL300320I1 (nl) 2008-03-03
LU91398I2 (fr) 2008-02-14
LU91393I2 (fr) 2008-02-14
US8012679B1 (en) 2011-09-06
DE122007000101I1 (de) 2008-03-27
NL300321I1 (nl) 2008-03-03
LU91394I2 (fr) 2008-02-14

Similar Documents

Publication Publication Date Title
NL300320I1 (nl) Papillomavirus vaccins
DE122008000010I1 (de) Sich selbst-zusammenbauende rekombinante hpv16 papillomavirus-hüllproteine